NISS/Merck Meetup: Bayesian Statistics in Drug Development

Video Source: https://www.niss.org/news/bayesian-statistics-focus-popular-nissmerck-meetup

NISS-Merck Virtual Meet-up on Bayesian Statistics in Drug Development

Discussion held April 27, 2020.
Moderated by Don Holder, Executive Director, BARDS, Merck

04:00 Fundamental Advantages of Bayes in Drug Development
Frank Harrell, Professor of Biostatistics at Vanderbilt University’s School of Medicine

26:23 Bayesian Applications for Extrapolation from Adult to Pediatric Data
Amy Xia, Vice President of the Biostatistics, Design & Innovation division at Amgen

49:50 The Value of Bayesian Approaches in the Regulatory Setting
Telba Irony, Deputy Directory of Biostatistics and Epidemiology at the FDA’s Center for Biologics Evaluation and Research